Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Common Stock Subscribed [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Subscription Receivable [Member]
Total
Balance (in shares) at Dec. 31, 2019 7,621,338 0          
Balance at Dec. 31, 2019 $ 46 $ 0 $ 55,055 $ (39,561) $ 31 $ 0 $ 15,571
Issuance of common stock, net of issuance costs (in shares) 1,250,000 0          
Issuance of common stock, net of issuance costs $ 7 $ 0 559 0 0 0 566
Stock-based compensation 0 0 397 0 0 0 397
Consolidated net loss 0 0 0 (1,209) 0 0 (1,209)
Cumulative translation adjustment 0 0 0 0 (33) 0 (33)
Net loss $ 0 $ 0 0 (1,209) 0 0 (1,209)
Balance (in shares) at Mar. 31, 2020 8,871,338 0          
Balance at Mar. 31, 2020 $ 53 $ 0 56,011 (40,770) (2) 0 15,292
Balance (in shares) at Dec. 31, 2019 7,621,338 0          
Balance at Dec. 31, 2019 $ 46 $ 0 55,055 (39,561) 31 0 15,571
Consolidated net loss             (11,321)
Cumulative translation adjustment             (8)
Net loss             (11,321)
Balance (in shares) at Jun. 30, 2020 10,067,250 0          
Balance at Jun. 30, 2020 $ 60 $ 0 66,428 (50,882) 23 0 15,629
Balance (in shares) at Mar. 31, 2020 8,871,338 0          
Balance at Mar. 31, 2020 $ 53 $ 0 56,011 (40,770) (2) 0 15,292
Issuance of common stock, net of issuance costs (in shares) 1,195,162 0          
Issuance of common stock, net of issuance costs $ 7 $ 0 10,000 0 0 0 10,007
Warrants exercised (in shares) 750 0          
Warrants exercised $ 0 $ 0 9 0 0 0 9
Stock-based compensation 0 0 408 0 0 0 408
Consolidated net loss 0 0 0 (10,112) 0 0 (10,112)
Cumulative translation adjustment 0 0 0 0 25 0 25
Net loss $ 0 $ 0 0 (10,112) 0 0 (10,112)
Balance (in shares) at Jun. 30, 2020 10,067,250 0          
Balance at Jun. 30, 2020 $ 60 $ 0 66,428 (50,882) 23 0 15,629
Balance (in shares) at Dec. 31, 2020 11,536,720 26,966          
Balance at Dec. 31, 2020 $ 69 $ 0 74,671 (56,916) 65 (129) 17,760
Issuance of common stock, net of issuance costs (in shares) 16,883,420 (26,966)          
Issuance of common stock, net of issuance costs $ 18 $ 0 74,537 0 0 129 74,684
Reverse stock split (in shares) 14,285 0          
Reverse stock split $ (60) $ 0 60 0 0 0 0
Warrants exercised (in shares) 10,000 0          
Warrants exercised $ 1 $ 0 115 0 0 0 116
Stock-based compensation 0 0 405 0 0 0 405
Consolidated net loss 0 0 0 (4,445) 0 0 (4,445)
Cumulative translation adjustment 0 0 0 0 (4) 0 (4)
Net loss $ 0 $ 0 0 (4,445) 0 0 (4,445)
Balance (in shares) at Mar. 31, 2021 28,444,425 0          
Balance at Mar. 31, 2021 $ 28 $ 0 149,788 (61,361) 61 0 88,516
Balance (in shares) at Dec. 31, 2020 11,536,720 26,966          
Balance at Dec. 31, 2020 $ 69 $ 0 74,671 (56,916) 65 (129) 17,760
Consolidated net loss             (8,689)
Cumulative translation adjustment             (10)
Net loss             (8,689)
Balance (in shares) at Jun. 30, 2021 28,552,213 2,500          
Balance at Jun. 30, 2021 $ 29 $ 0 150,231 (65,605) 55 (10) 84,700
Balance (in shares) at Mar. 31, 2021 28,444,425 0          
Balance at Mar. 31, 2021 $ 28 $ 0 149,788 (61,361) 61 0 88,516
Issuance of common stock, net of issuance costs (in shares) 107,788 0          
Issuance of common stock, net of issuance costs $ 1 $ 0 0 0 0 0 1
Stock-based compensation 0 0 433 0 0 0 433
Consolidated net loss 0 0 0 (4,244) 0 0 (4,244)
Cumulative translation adjustment $ 0 $ 0 0 0 (6) 0 (6)
Subscription of common stock in connection with Consulting Agreement (in shares) 0 2,500          
Subscription of common stock in connection with Consulting Agreement $ 0 $ 0 10 0 0 (10) 0
Net loss $ 0 $ 0 0 (4,244) 0 0 (4,244)
Balance (in shares) at Jun. 30, 2021 28,552,213 2,500          
Balance at Jun. 30, 2021 $ 29 $ 0 $ 150,231 $ (65,605) $ 55 $ (10) $ 84,700